Overweight CVX with scaled 30% Tier 1 entry; 40% reserve for flush or reclaim triggers
Overweight CVX at $203-205 targets $230 on 17x re-rate of $13.57 forward EPS; Q3 2026 earnings is the binary event. Reduce initial tranche to 30% (from 50%) given multi-confirmed momentum deterioration that has produced marginal alpha on every recent Overweight; ATR elevated 12% above summer baseline ($4.35 vs $3.87) means standard sizing is over-exposure. Structural floor intact: 200 SMA at $182.64, sub-1x Net Debt/EBITDA, 37-year Aristocrat streak, 0.49 beta compresses drawdowns, 3.46% dividend provides carry. Sell covered calls at $215-220/Dec expiry to monetize elevated IV. Hard stop $195.84 daily close; structural exit $182.64 weekly close.
| Position | Action |
|---|---|
| Tier 1: MACD bearish cross intact; RSI 72→48 without oversold bounce; 50 SMA buffer +2.1% | Initiate 30% position at $203-205 (reduced from 50% per Sept 21-23 marginal-alpha pattern) |
| Tier 2: Price reaches $200.31/$200.63 confluence zone | Add 30% position; requires MACD histogram compression toward zero (not just price touch) |
| Tier 3: $195.84 July-low flush with bullish reversal candle | Add 20% position |
| Tier 4: Confirmed 10 EMA reclaim at ~$207 with histogram turn positive | Add 20% position |
CVX is mispriced at $204, offering a forward P/E of 15.1x on $13.57 EPS with 30%+ earnings growth, fortress balance sheet deleveraging, and multi-front growth optionality from Guyana, Venezuela, and LNG positions.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 207.00 | bearish |
| 50 SMA | 200.31 | bullish |
| 200 SMA | 182.64 | bullish |
| RSI (14) | 48.12 | neutral |
| MACD | 1.45 | bearish |
| MACD Signal | 3.08 | bearish |
| MACD Histogram | -1.63 | bearish |
| ATR (14) | 4.35 | neutral |
Support: 200.63 · 200.31 · 195.84 · 182.64 | Resistance: 207 · 209.27 · 213.81 · 217.77 · 217.92
CVX's long-term technical picture remains constructive with price holding above the 200 SMA by ~12%, but short-term momentum has deteriorated significantly—MACD crossed below its signal line on 2026-09-16 with the histogram widening to -1.63, and RSI collapsed from overbought (>70) to neutral (48.12) without a meaningful bounce, confirming momentum exhaustion. The 200.63/200.31 zone (Bollinger lower band + 50 SMA) is the high-conviction support; a daily close below 200 opens downside toward the July swing low at 195.84. Bullish invalidation requires a reclaim of the 10 EMA at 207.00 with the MACD histogram turning positive.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price at $200.31/$200.63 with MACD histogram compression toward zero
Then: Deploy 30% of position
Hess deal closed mid-2025 and is already delivering transformational equity income
↩ rebuts: “Bear claim that elevated Q2 equity income may not repeat”
EV: +$240+ · concedes: Q2 had outsized equity-income contributions ($2.13B vs $0.75B in Q1) that may not fully repeat in future quarters; Energy transition risk is a valid 10-15 year concern, though CVX has navigated 37 years of dividend growth through every prior 'end of oil' call; 10 EMA not reclaimed for five sessions represents short-term technical weakness
Chevron at $204 is a value trap; the "earnings inflection" is cyclical M&A noise masking deteriorating fundamentals, with technicals two sessions from a confirmed bearish breakdown and macro headwinds rising.
· concedes: Q2 2026 was an impressive quarter: $12.07B net income, $6.11 EPS, $18.1B FCF; Forward EPS of $13.57 implies 30% growth from TTM EPS of $10.41; Equity income contribution of $2.13B (vs. $0.75B baseline) is real if it repeats
→ vs conservative: Waiting for confirmation (price at $2.17, RSI at 72) means chasing breakouts with everyone else and missing value investing opportunities during sentiment wobbles
→ vs conservative: MACD bearish cross is momentum oscillator reacting to 7% pullback from $2.17 to $2.02 over 5 sessions—normal mean reversion, not fundamental deterioration
→ vs neutral: HOLD thesis with bullish bias is contradictory—recommending sitting on hands while naming CVX a 'quality relative outperformer' with constructive growth pipeline
→ vs neutral: Weekly dividend yield (~7 basis points) evaporates while waiting for pullback that may never materialize at meaningful level
→ vs conservative: Diesel export ban risk is being overweighted; coordinated lobbying by entire integrated refining complex (CVX, XOM, PSX, VLO) makes admin override unlikely during geopolitical tension
→ vs conservative: Bearish case requires ALL three to break simultaneously: forward EPS disappointment, 50 SMA support failure, and macro regime flip against dividend payers
Market Cap
$401.05B
P/E (TTM)
19.6x
Forward P/E
15.1x
PEG Ratio
0.9
P/B
2.11x
Dividend Yield
3.46%
Beta
0.491
Revenue (TTM)
$209.38B
EBITDA (TTM)
$50.66B
Net Income (TTM)
$20.59B
EPS (TTM)
$10.41
Forward EPS
$13.57
Gross Margin
44.3%
Operating Margin
21.9%
Net Profit Margin
9.8%
ROE
12.2%
ROA
5.9%
Total Assets
$330.1B
Total Equity
$195.6B
Total Debt
$37.1B
Net Debt
$28.5B
Debt/Capital
~19%
Current Ratio
1.25
Book Value/Share
$96.80
Free Cash Flow (TTM)
$21.9B
Q2 2026 FCF
$18.1B
Buybacks (2025)
$12.1B
Dividends (2025)
$12.8B
Annualized Dividend Run-rate
~$14.0B
52-Week High
$217.78
52-Week Low
$146.49
50-day MA
$200.67
200-day MA
$184.97
Goodwill
$4.6B
Annual Capex
$17.3B
Hess Acquisition Cost
~$60B
Q2 2025 Revenue
$44.38B
Q3 2025 Revenue
$48.17B
Q4 2025 Revenue
$45.79B
Q1 2026 Revenue
$47.56B
Q2 2026 Revenue
$67.20B
Q2 2026 Net Income
$12.07B
Q2 2026 EPS
$6.11
Q2 2026 EBITDA
$23.03B
Equity Income Q2 2026
$2.13B
Revenue 2022
$235.7B
Revenue 2023
$196.9B
Revenue 2024
$193.4B
Revenue 2025
$184.4B
Net Income 2022
$35.5B
Net Income 2023
$21.4B
Net Income 2024
$17.7B
Net Income 2025
$12.3B
EPS 2022
$18.28
EPS 2023
$11.36
EPS 2024
$9.72
EPS 2025
$6.63
FCF 2022
$37.6B
FCF 2023
$19.8B
FCF 2024
$15.0B
FCF 2025
$16.6B
Dividend Growth Streak
37+ years
Strengths
Concerns
HOLD/BUY on pullbacks toward 200-day MA (~$185) — The fundamental backdrop is constructive with Q2 2026 demonstrating substantial inflection driven by Hess synergies, Guyana production ramp, and higher commodity prices. Valuation at forward P/E 15.1x is reasonable given 30% expected EPS growth, with capital returns providing a strong floor at current prices.
Macro: 10-year Treasury yield at highest level since 2007 (approaching ~5%); 30-year yield at highest since 2004. Mortgage rates toward 7.5%. US recession risk at 10% (up +2pp week-over-week). Crude easing from highs; geopolitical premium fading (0% chance of new all-time-high crude by Sept 30; 10% by Dec 31). Polymarket consensus decisively hawkish at 96% probability of no Fed cuts in 2026.